Fulgent Genetics, Inc.FLGTNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank18
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P18
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$-44.34M+9.5%
2024$-48.99M+66.8%
2023$-147.45M-167.7%
2022$217.70M-68.3%
2021$686.96M+134.4%
2020$293.12M+17358.0%
2019$1.68M+157.8%
2018$-2.91M-65.7%
2017$-1.75M-184.0%
2016$2.09M-